Induction of nuclear translocation of constitutive androstane receptor by peroxisome proliferator-activated receptor α synthetic ligands in mouse liver

被引:32
|
作者
Guo, Dongsheng
Sarkar, Joy
Suino-Powell, Kelly
Xu, Yong
Matsumoto, Kojiro
Jia, Yuzhi
Yu, Songtao
Khare, Sonal
Haldar, Kasturi
Rao, M. Sambasiva
Foreman, Jennifer E.
Monga, Satdarshan P. S.
Peters, Jeffrey M.
Xu, H. Eric
Reddy, Janardan K.
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA
[2] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA
[3] Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA
[4] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA
关键词
D O I
10.1074/jbc.M707183200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peroxisome proliferators activate nuclear receptor peroxisome proliferator-activated receptor alpha ( PPAR alpha) and enhance the transcription of several genes in liver. We report here that synthetic PPAR alpha ligands Wy-14,643, ciprofibrate, clofibrate, and others induce the nuclear translocation of constitutive androstane receptor (CAR) in mouse liver cells in vivo. Adeno-viral-enhanced green fluorescent protein-CAR expression demonstrated that PPAR alpha synthetic ligands drive CAR into the hepatocyte nucleus in a PPAR alpha- and PPAR beta-independent manner. This translocation is dependent on the transcription coactivator PPAR-binding protein but independent of coactivators PRIP and SRC-1. PPAR alpha ligand-induced nuclear translocation of CAR is not associated with induction of Cyp2b10 mRNA in mouse liver. PPAR alpha ligands interfered with coactivator recruitment to the CAR ligand binding domain and reduced the constitutive transactivation of CAR. Both Wy-14,643 and ciprofibrate occupied the ligand binding pocket of CAR and adapted a binding mode similar to that of the CAR inverse agonist androstenol. These observations, therefore, provide information for the first time to indicate that PPAR alpha ligands not only serve as PPAR alpha agonists but possibly act as CAR antagonists.
引用
收藏
页码:36766 / 36776
页数:11
相关论文
共 50 条
  • [31] Peroxisome proliferator-activated receptor γ and atherosclerosis
    Marx, N
    CURRENT HYPERTENSION REPORTS, 2002, 4 (01) : 71 - 77
  • [32] Peroxisome proliferator-activated receptor γ ligands suppress liver carcinogenesis induced by diethylnitrosamine in rats
    Yan-Tong Guo Jing-Ming Zhao Xi-Hou Lin Department of General Surgery
    World Journal of Gastroenterology, 2004, (23) : 3419 - 3423
  • [33] Peroxisome proliferator-activated receptor agonists
    Willson, TM
    Wahli, W
    CURRENT OPINION IN CHEMICAL BIOLOGY, 1997, 1 (02) : 235 - 241
  • [34] Induction of Lysosomal Biogenesis by Activating Peroxisome Proliferator-Activated Receptor α
    Ghosh, A.
    Jana, M.
    Modi, K.
    Babu, S.
    Gonzalez, F. J.
    Sims, K. B.
    Berry-Kravis, E.
    Pahan, K.
    CELL TRANSPLANTATION, 2015, 24 (04) : 758 - 759
  • [35] Peroxisome proliferator-activated receptor γ and cancers
    Koeffler, HP
    CLINICAL CANCER RESEARCH, 2003, 9 (01) : 1 - 9
  • [36] Chondrosarcoma and Peroxisome Proliferator-Activated Receptor
    Nishida, K.
    Kunisada, T.
    Shen, Z. N.
    Kadota, Y.
    Hashizume, K.
    Ozaki, T.
    PPAR RESEARCH, 2008, 2008
  • [37] Peroxisome proliferator-activated receptor γ and atherosclerosis
    Nikolaus Marx
    Current Hypertension Reports, 2002, 4 : 71 - 77
  • [39] The peroxisome proliferator-activated receptor δ, an integrator of transcriptional repression and nuclear receptor signaling
    Shi, YH
    Hon, M
    Evans, RM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (05) : 2613 - 2618
  • [40] Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor α interacting protein
    Dowell, P
    Ishmael, JE
    Avram, D
    Peterson, VJ
    Nevrivy, DJ
    Leid, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (22) : 15901 - 15907